Novo Nordisk India Cuts Prices of Weight Loss, Diabetes Drugs

Novo Nordisk India has cut prices of its blockbuster weight-loss and diabetes medications, as an onset of cheaper generic drugs raises competition for the Danish drugmaker in the world’s third most overweight country.

Read More: Ozempic Copies at $14 in India as Novo Patent Expires